Runming Jin
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Modeling and Simulation top 5%
Papers in
-
- Ion Transport and Channel Regulation 5
- Hematology 22
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 5
- Co-authors
- Hongbo Chen (13 shared papers)Tianyou Wang (2 shared papers)Dongchi Zhao (2 shared papers)Sainan Shu (2 shared papers)Liwei Gao (1 shared paper)Baoping Xu (1 shared paper)Kunling Shen (1 shared paper)Xuefeng Wang (1 shared paper)
- Journals
- World Journal of Pediatrics (3 papers)Blood (3 papers)Frontiers in Pediatrics (2 papers)Frontiers in Oncology (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Runming Jin
88 papers receiving 2.3k citations
Runming Jin's Hit Papers
Peers
Comparison fields: 5 of 145
- Infectious Diseases 519
- Modeling and Simulation 86
- Obstetrics and Gynecology 106
- Hematology 144
- Oncology 256
Countries citing papers authored by Runming Jin
This map shows the geographic impact of Runming Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runming Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runming Jin more than expected).
Fields of papers citing papers by Runming Jin
This network shows the impact of papers produced by Runming Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runming Jin. The network helps show where Runming Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Runming Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement Hit paper breakdown → | 2020 | 563 |
| 2 | Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension Hit paper breakdown → | 2020 | 239 |
| 3 | 2016 | 204 | |
| 4 | 2020 | 106 | |
| 5 | 2009 | 105 | |
| 6 | 2019 | 102 | |
| 7 | 2021 | 89 | |
| 8 | 2019 | 66 | |
| 9 | 2020 | 56 | |
| 10 | 2019 | 49 | |
| 11 | 2008 | 47 | |
| 12 | 2009 | 43 | |
| 13 | 2019 | 32 | |
| 14 | 2011 | 32 | |
| 15 | 1999 | 31 | |
| 16 | 2013 | 28 | |
| 17 | 2020 | 28 | |
| 18 | 2020 | 27 | |
| 19 | 2021 | 26 | |
| 20 | 2020 | 21 |
About Runming Jin
Runming Jin is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Oncology and Infectious Diseases, having authored 96 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (19 papers), Acute Myeloid Leukemia Research (12 papers), Childhood Cancer Survivors' Quality of Life (9 papers), COVID-19 Clinical Research Studies (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Ion Transport and Channel Regulation (5 papers), Immune Cell Function and Interaction (5 papers) and Neutropenia and Cancer Infections (4 papers). The work is most often cited by research in Infectious Diseases (519 citations), Modeling and Simulation (86 citations), Obstetrics and Gynecology (106 citations), Hematology (144 citations) and Oncology (256 citations). Runming Jin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hongbo Chen, Tianyou Wang, Dongchi Zhao, Sainan Shu, Liwei Gao, Baoping Xu, Kunling Shen, Xuefeng Wang, Yunxiao Shang and Yongyan Wang. Their work appears in journals such as World Journal of Pediatrics, Blood, Frontiers in Pediatrics, Frontiers in Oncology and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.